|
FDA Warns Patients to Regularly Check Smartphone Alert Settings for Diabetes Devices
|
Written by: J. Smith |
Hits: 1003
|
|
FDA Approves Merilog, the First Rapid-Acting Insulin Biosimilar
|
Written by: J. Smith |
Hits: 774
|
|
FDA Declares Semaglutide Shortage Resolved, Raising Concerns Over Compounded Versions
|
Written by: J. Smith |
Hits: 596
|
|
Controversial Super Bowl Ad Sparks Debate Over Compounded GLP-1 Medications
|
Written by: J. Smith |
Hits: 612
|
|
Novo Nordisk's CagriSema Gains Momentum Amid Investor Optimism and Legal Scrutiny
|
Written by: J. Smith |
Hits: 769
|
|
FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 615
|
|
Novo Nordisk's Amycretin Shows 22% Weight Loss in Early Trial Results
|
Written by: J. Smith |
Hits: 750
|
|
Novo Nordisk and Valo Health Expand AI-Powered Partnership to Address Cardiometabolic Diseases
|
Written by: J. Smith |
Hits: 488
|
|
Semaglutide 7.2 mg Demonstrates Greater Weight Loss but Faces Market Challenges
|
Written by: J. Smith |
Hits: 519
|
|
2025 Outlook: GLP-1 Supply Gains Momentum Amid Expansion Efforts
|
Written by: J. Smith |
Hits: 3986
|
